Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct;67(2 Pt A):117-30.
doi: 10.1016/j.molimm.2015.01.028. Epub 2015 Feb 17.

Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics

Joost P M Melis  1 , Kristin Strumane  1 , Sigrid R Ruuls  1 , Frank J Beurskens  1 , Janine Schuurman  1 , Paul W H I Parren  2
Affiliations
Free article
Review

Complement in therapy and disease: Regulating the complement system with antibody-based therapeutics

Joost P M Melis et al. Mol Immunol. 2015 Oct.
Free article

Abstract

Complement is recognized as a key player in a wide range of normal as well as disease-related immune, developmental and homeostatic processes. Knowledge of complement components, structures, interactions, and cross-talk with other biological systems continues to grow and this leads to novel treatments for cancer, infectious, autoimmune- or age-related diseases as well as for preventing transplantation rejection. Antibodies are superbly suited to be developed into therapeutics with appropriate complement stimulatory or inhibitory activity. Here we review the design, development and future of antibody-based drugs that enhance or dampen the complement system.

Keywords: Antibody; Antibody engineering; Cancer; Complement; Immunology; Therapy.

PubMed Disclaimer

MeSH terms